Skip to main content

Table 1 Demographic, Clinical and Operative Data of Patients

From: COVID-19 outbreak and acute cholecystitis in a Hub Hospital in Milan: wider indications for percutaneous cholecystostomy

Age (yo—mean and range) 64 (38–94)
Sex (%)  
 Male 21 (56.7%)
 Female 16 (43.3%)
 BMIa (mean ± SD) 26. 5 (± 3.9)
ASAb score (%)  
 1–2 27 (72.9%)
 3–4 10 (27.1%)
CCIc (%)  
  < 6 32 (86.5%)
  ≥ 6 5 (13.5%)
Severity grade according to 2018 Tokyo Guidelines (%)  
 Grade I 13 (35.1%)
 Grade II 16 (43.3%)
 Grade III 8 (21.6%)
Treatment (%)  
 Antibiotics only 11 (29.7%)
 PCd 8 (21.6%)
 LCe 18 (48.6%)
  1. aBody Mass Index; bAmerican Society of Anesthesiology;cCharlson Comorbidity Index; d Percutaneous cholecystostomy; eLaparsocopic cholecystectomy